Amount of net assets (liabilities).

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 30
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 205
-Section 45
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 220
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(7))
-URI https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section S99
-Paragraph 2
-Subparagraph (SX 210.6-05(4))
-URI https://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 220
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(6))
-URI https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272

Name:	us-gaap_AssetsNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Acquisition of Flame Biosciences - Net assets acquired (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Jan. 17, 2023	Dec. 31, 2022
Acquisition of Flame Biosciences
Cash and cash equivalents	$ 102,038		$ 65,500
Flame
Acquisition of Flame Biosciences
Acquired I P R & D		$ 29,582
Cash and cash equivalents	$ 29,582	50,362
Accounts payable and accrued liabilities		(928)
Total acquisition value		$ 79,016